Mahaney Paige - Insider Non-Derivative Transactions at C4 Therapeutics, Inc. (CCCC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 28, 2025, Mahaney Paige's relationship to C4 Therapeutics, Inc. (CCCC) is Officer (Chief Scientific Officer), and currently has 105,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CCCC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Mahaney Paige - Insider Non-Derivative Transactions of CCCC Common Stock

Mahaney Paige - Insider Non-Derivative Transactions at CCCC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 29, 2025	F -- (Common Stock)	5644	2.58	99356
Oct 29, 2025	M -- (Common Stock)	19200	0	105000
Feb 15, 2025	Acquisition -- (Common Stock)	28200	0	105000
Oct 29, 2024	Acquisition -- (Common Stock)	76800	0	76800